Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-05

Clinical Trial Update: Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dexmedetomidine to placebo for pediatric cleft palate repair has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cleft Palate | Phase 4 | Status: WITHDRAWN